These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 2402267

  • 1. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Gold R, Meurers B, Reichmann H.
    N Engl J Med; 1990 Oct 04; 323(14):994. PubMed ID: 2402267
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C, Baudrimont M, Bonne G, Geny C, Degoul F, Marsac C, Roullet E, Gherardi R.
    Ann Neurol; 1991 Jun 04; 29(6):606-14. PubMed ID: 1892364
    [Abstract] [Full Text] [Related]

  • 4. Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine.
    Herzberg NH, Zorn I, Zwart R, Portegies P, Bolhuis PA.
    Muscle Nerve; 1992 Jun 04; 15(6):706-10. PubMed ID: 1324428
    [Abstract] [Full Text] [Related]

  • 5. HIV or zidovudine myopathy?
    Dalakas M.
    Neurology; 1994 Feb 04; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
    [No Abstract] [Full Text] [Related]

  • 6. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.
    Scruggs ER, Dirks Naylor AJ.
    Pharmacology; 2008 Feb 04; 82(2):83-8. PubMed ID: 18504416
    [Abstract] [Full Text] [Related]

  • 7. HIV or zidovudine myopathy?
    Gherardi R, Chariot P.
    Neurology; 1994 Feb 04; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract] [Full Text] [Related]

  • 8. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
    Pezeshkpour G, Illa I, Dalakas MC.
    Hum Pathol; 1991 Dec 04; 22(12):1281-8. PubMed ID: 1748434
    [Abstract] [Full Text] [Related]

  • 9. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
    Schröder JM, Bertram M, Schnabel R, Pfaff U.
    Acta Neuropathol; 1992 Dec 04; 85(1):39-47. PubMed ID: 1285495
    [Abstract] [Full Text] [Related]

  • 10. [Muscular involvement in HIV infection].
    Gherardi R, Chariot P, Authier FJ.
    Rev Neurol (Paris); 1995 Nov 04; 151(11):603-7. PubMed ID: 8745623
    [Abstract] [Full Text] [Related]

  • 11. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ, McLean KA, Moss J, Woodrow DF.
    Neuropathol Appl Neurobiol; 1993 Oct 04; 19(5):406-13. PubMed ID: 8278024
    [Abstract] [Full Text] [Related]

  • 12. [Muscular complications in HIV infection].
    Authier FJ, Chariot P, Gherardi R.
    Arch Anat Cytol Pathol; 1997 Oct 04; 45(2-3):174-8. PubMed ID: 9382610
    [Abstract] [Full Text] [Related]

  • 13. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC, Barker SM, Mitchell DH, Stevens SM, O'Neill P, Cunningham AL.
    Pathology; 1992 Apr 04; 24(2):109-11. PubMed ID: 1641255
    [Abstract] [Full Text] [Related]

  • 14. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR, Shebert R, Gregorios JB.
    AIDS; 1991 Feb 04; 5(2):229-30. PubMed ID: 2031699
    [No Abstract] [Full Text] [Related]

  • 15. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
    Peters BS, Winer J, Landon DN, Stotter A, Pinching AJ.
    Q J Med; 1993 Jan 04; 86(1):5-15. PubMed ID: 8438050
    [Abstract] [Full Text] [Related]

  • 16. 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients.
    Weissman JD, Constantinitis I, Hudgins P, Wallace DC.
    Neurology; 1992 Mar 04; 42(3 Pt 1):619-23. PubMed ID: 1549225
    [Abstract] [Full Text] [Related]

  • 17. Images in clinical medicine. Zidovudine myopathy.
    Chariot P.
    N Engl J Med; 1993 Jun 10; 328(23):1675. PubMed ID: 11407398
    [No Abstract] [Full Text] [Related]

  • 18. [Toxic drug-induced proximal myopathy in CDC C3 HIV-infection].
    Weisser M.
    Praxis (Bern 1994); 1997 Oct 22; 86(43):1708-10. PubMed ID: 9432697
    [No Abstract] [Full Text] [Related]

  • 19. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.
    Semino-Mora MC, Leon-Monzon ME, Dalakas MC.
    Lab Invest; 1994 Jul 22; 71(1):102-12. PubMed ID: 7518879
    [Abstract] [Full Text] [Related]

  • 20. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM, Masanés F, Pedrol E, Casademont J, Fernández-Solá J, Urbano-Márquez A.
    Ann Neurol; 1993 Aug 22; 34(2):206-11. PubMed ID: 8338345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.